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Abstract
Native cholera toxin (nCT) as a nasal adjuvant was shown to elicit increased levels of T-independent S-IgA antibody (Ab)
responses through IL-5- IL-5 receptor interactions between CD4
+ T cells and IgA
+ B-1 B cells in murine submandibular glands
(SMGs) and nasal passages (NPs). Here, we further investigate whether oral-nasopharyngeal dendritic cells (DCs) play a
central role in the induction of B-1 B cell IgA class switch recombination (CSR) for the enhancement of T cell-independent
(TI) mucosal S-IgA Ab responses. High expression levels of activation-induced cytidine deaminase, Ia-Cm circulation
transcripts and Im-Ca transcripts were seen on B-1 B cells purified from SMGs and NPs of both TCRb
2/2 mice and wild-type
mice given nasal trinitrophenyl (TNP)-LPS plus nCT, than in the same tissues of mice given nCT or TNP-LPS alone. Further,
DCs from SMGs, NPs and NALT of mice given nasal TNP-LPS plus nCT expressed significantly higher levels of a proliferation-
inducing ligand (APRIL) than those in mice given TNP-LPS or nCT alone, whereas the B-1 B cells in SMGs and NPs showed
elevated levels of transmembrane activator and calcium modulator cyclophilin ligand interactor (TACI) expression.
Interestingly, high frequencies of IgA
+ B-1 B cells were induced when peritoneal IgA
2 IgM
+ B cells were stimulated with
mucosal DCs from mice given nasal TNP-LPS plus nCT. Taken together, these findings show that nasal nCT plays a key role in
the enhancement of mucosal DC-mediated TI IgA CSR by B-1 B cells through their interactions with APRIL and TACI.
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Introduction
Immunoglobulin A (IgA) antibody (Ab) is known as the most
abundant Ig isotype in humans, and this isotype is induced by
cellular and molecular mucosal interactions between IgA-commit-
ted B cells, helper CD4
+ T cells, epithelial cells and their derived
cytokines. [1,2] In order to induce efficient antigen (Ag)-specific
IgA Ab responses, live attenuated viral or bacterial delivery
systems or mucosal adjuvants are generally required. Mucosal
adjuvants, including enterotoxins [3,4], cytokines [5,6], chemo-
kines [7], toll-like receptor ligands [8] and growth factors [9] offer
the advantage of eliciting mucosal as well as parenteral immune
responses [10]. Of these, native cholera toxin (nCT) is the most
widely used mucosal adjuvant for the induction of both mucosal
and systemic immunity to co-administered protein Ags in mice.
Thus, nasal administration of nCT as mucosal adjuvant
preferentially induces characteristic plasma IgG1, IgG2b, IgE
and IgA as well as mucosal S-IgA Ab responses to T cell-
dependent (TD) Ags, which are mediated through CD4
+ Th2-type
cells and their derived cytokines [3,11–13].
Nasopharyngeal-associated lymphoreticular tissue (NALT) and
Peyer’s patches are specialized lymphoid tissue clusters known as
mucosal inductive sites where IgA-committed B cells undergo m to a
isotype class switching. Subsequently, IgA-committed B cells
migrate to diffuse mucosal effector tissues, including the nasal
passages (NPs) and intestinal lamina propria (iLP), respectively
[14,15]. In addition to these mucosal inductive tissues, it is known
that IgA CSR occurs in the absence of T cells in the iLP [16–18].
Similarly, B cells of the isolated lymphoid follicles (ILFs), scattered
throughout the intestine, can undergo IgA CSR either from actual
bacterial infection or from constant surveillance of commensals
[19,20]. In this regard, both in vitro and in vivo studies have shown
that a proliferation inducing ligand (APRIL) promotes T cell-
independent (TI) CSR of IgA via engagement of transmembrane
activator and calcium modulator cyclophilin ligand interactor
(TACI) [21–23]. Recent studies reported that retinoic acid-
producing DCs from mucosa-associated lymphoreticular tissue
induce surface IgA and gut homing receptor expression on B cells in
a TI manner [24]. Since APRIL binds firmly to B-cell maturation
antigen (BCMA)inadditiontoTACI,APRILonDCsinteractswith
BCMA and TACI on B cells in order to induce IgA CSR [25].
B-1 B cells differ from conventional B cells in cell surface protein
CD5 expression, anatomical localization and functional characteris-
tics [26–28]. With regard to function, B-1 B cells differentiate
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polysaccharide Ag. Although these responses can be enhanced/
increased by T cells, they appear within 48 hr of exposure to Ag and
are not dependent upon T cell help. B-1 B cells in the murine
peritoneal cavity and iLP have been shown to develop from a
common pool and may represent a lineage separate from
conventional PP B cells [29]. Other studies using transgenic mice
have provided additional supportive evidence that intestinal IgA
plasma cells are derived from B-1 B cells [30]. Furthermore, it has
been shown that intestinal mucosal IgA Abs with specificity for
commensal bacteria are produced by B-1 B cells in a TI manner
[31,32]. These studies clearly suggest that B-1 B cells are an
important source of IgA-producing cells in the intestinal mucosal
tissues.
Although IgA
+ B cell isotype switching is known to occur in
organized mucosal inductive lymphoid tissues such as PPs, NALT
and ILFs [33], little information is available regarding the cellular
and molecular mechanisms underlying IgA class switch recombi-
nation (CSR) to TI Ag in the oral and nasal mucosa. We have
previously reported that nCT can be used as an adjuvant to
enhance the induction of TI Ag, i.e., TNP-LPS-specific mucosal S-
IgA Ab responses through an interaction between IL-5 receptor-
expressing B-1 B cells and IL-5-producing CD4
+ T cells in the
SMGs and NPs [34]. In this study, we hypothesized that IgA
switching occurs in B-1 B cells in the SMGs and NPs via the Ig
isotype switching-associated molecules produced by mucosal DCs.
Here we focused on the cellular and molecular mechanisms for the
induction of IgA CSR induced by nasal nCT as a mucosal
adjuvant for immune responses to TI Ags.
Materials and Methods
Mice and nasal immunization
Female C57BL/6 mice were purchased from SLC Japan (Tokyo,
Japan) and were transferred to microisolators, maintained in
horizontal laminar flow cabinets in the University of Tokushima
animal facility. TCRb-deficient (TCRb
2/2)m i c ew e r eb a r r i e r
maintained in Trexler isolators in the University of Alabama at
Birmingham (UAB) animal facility. These mice were provided sterile
food and water as part of a specific pathogen free facility. All of the
mice were 8 to 12 wks old and free of bacterial and viral pathogens
when used for these experiments. All mice were housed and used in
accordance with the University of Tokushima and UAB guidelines
for the care and use of laboratory animals. Mice were immunized
nasally with 10 mg of TNP-LPS (Sigma Aldrich Co.) in the presence
(experimental group) or absence (control group) of native CT (nCT,
1 mg) (List Biological Laboratories Inc.) under anesthesia. In some
experiments, mice were given nasal PBS or nCT alone (1 mg).
Isolation of mononuclear cells from mucosal tissues and
enumeration of IgA-producing cells
Mononuclear cells were isolated from the submandibular glands
(SMGs), nasal passages (NPs) and nasopharyngeal associated
lymphoid tissues (NALT), as described previously. Briefly,
mononuclear cells from SMGs were isolated by an enzymatic
dissociation procedure with collagenase type IV (0.5 mg/ml;
Sigma) followed by a discontinuous Percoll (GE Healthcare Bio-
Sciences) gradient centrifugation step [34]. For isolation of NPs, a
modified dissociation method based upon a previously described
protocol was used [34,35]. Mononuclear cells from NALT were
obtained using a mechanical dissociation method that involved
gentle teasing through stainless steel wire screens as described
elsewhere [5,34,35]. In some experiments, mononuclear cells
obtained from SMGs and NPs were subjected to an ELISPOT
assay to detect numbers of TNP-specific IgA Ab-forming cells
(AFCs). Briefly, 96-well nitrocellulose plates (Millititer HA;
Millipore Corporation) were coated with 10 mg/ml TNP-BSA.
The numbers of TNP-specific IgA AFCs were quantified with the
aid of a stereomicroscope, as well as ImmunoSpot Analyzer reader
(Cellular Technology Ltd.) as described elsewhere [34].
Flow cytometric analyses and cell sorting
The mononuclear cells from various mucosal tissues were
isolated 3 days after nasal immunization and preincubated with
purified CD16 mAb (Fc Block, 2 mg/ml; BD PharMingen).
Samples were then stained with PE-labeled anti-CD11c and
purified anti- BAFF (5A8; rat IgG1) or anti-APRIL (Sacha-2; rat
IgG2a) followed by FITC-conjugated anti-rat IgG1 or IgG2a
mAbs (BD Biosciences). Aliquots of samples were also incubated
with purified anti-BAFF receptor (BAFF-R) (7H22-E16; rat IgG1),
anti-TACI (8F10; rat IgG2a) or anti-BCMA (Vicky-2; rat IgG2a)
mAb followed by FITC-conjugated anti-rat IgG1 or IgG2a mAb.
These samples were further incubated with allophycocyanin
Table 1. Expression of AID, aCT, Im-Ca transcripts in B-1 B cells from the oral-nasopharyngeal effector and inductive tissues of mice
nasally immunized with TNP-LPS with/without nCT or nCT alone.
a, b, c
Mouse Tissue AID Ia-Cm (aCT) Im-Ca
nCT+TNP-LPS TNP-LPS nCT nCT+TNP-LPS TNP-LPS nCT nCT+TNP-LPS TNP-LPS nCT
C57BL/6 SMGs *
, # 6765.4 2363.4 1863.3 *
, # 3665.5 1364.0 9.261.8 *
, # 7266.9 1162.9 2666.2
NPs *
, # 6463.6 2468.8 2964.5 *
, # 3268.9 2465.7 1961.4 *
, # 7469.1 2165.3 3063.4
NALT *
, # 8469.2 2566.8 3765.4 *
, # 4167.4 2863.6 2864.5 *
, # 78611 1964.3 3264.8
TCRb
2/2 SMGs *
, # 3967.0 2063.7 2162.7 *
, # 2668.4 7.864.2 9.965.1 *
, # 60616 8.163.0 1162.2
NPs *
, # 4265.5 1864.9 1662.3 *
, # 2965.2 1863.5 2162.5 *
, # 62614 2265.9 3263.9
NALT *
, # 6268.8 1666.9 2563.4 *
, # 4569.4 1962.0 1661.9 *
, # 66615 2866.6 3064.1
aFive days after nasal immunization, B-1 B (CD5
+ B220
+) cells from the SMGs, NPs and NALT (as a positive control) were purified by FACS and were then subjected to
semi-quantitative RT-PCR.
bThe numbers are mean the expression percentages of the respective CSR-associated molecules when the density of b-actin expression on respective lymphoid tissues
was calculated as 100 with ChemiDoc XRS Quantity one Analysis software (Bio-Rad).
cThe values are presented as the mean 6 SEM of 10 mice for each group and represent a total of five separate experiments.
*p,0.05 when compared with mice given TNP-LPS alone.
#p,0.05 when compared with mice given nCT alone.
doi:10.1371/journal.pone.0025396.t001
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addition of 7-amino actinomycin D solution (Via-Probe; BD
Biosciences) to exclude dead cells. BAFF and APRIL, as well as
their receptor-specific mAbs originally from ALEXIS Biochemi-
cals (Lausen, Switzerland), were obtained from AXXORA, LLC
(San Diego, USA). In some experiments, mononuclear cells from
SMGs, NPs and NALT were taken 5 days after the nasal
immunization step and were stained with FITC-conjugated anti-
CD11c and PE-labeled anti-MHC class II, -CD40, -CD80, or
-CD86 mAbs (BD PharMingen). The samples were analyzed using
a FACSCalibur (BD Biosciences) and CellQuest software (BD
Immunocytometry Systems). In order to purify B-1 B cells, cells
were stained with anti-B220 and anti-CD5 mAbs and were then
subjected to FACSAria (DiVa 4.0) system (BD Biosciences).
Cell separation by AutoMACS
To obtainmucosal DCs,mononuclearcells from SMGs,NPsand
NALT were incubated with anti-CD11c labeled microbeads
(Miltenyi Biotec Inc.) according to the manufacture’s instructions
and were then positively selected with an AutoMACS. The purified
DC fraction consisted of .97% CD11c
+, with .99% cell viability.
Peritoneal IgA
2 B cells were collected as follows. Mice were
sacrificed, and the peritoneal cavity was gently washed with 5 ml
sterile PBS. The peritoneal cells in the washed PBS were incubated
with biotin-conjugated anti-IgA mAb, followed by streptavidin-
conjugated microbeads, and IgA
2 cells were negatively sorted using
AutoMACS. Subsequently, the IgA
2 cells wereincubatedwith anti-
B220 mAb-conjugated microbeads to isolate IgA
2 B cells.
Semi-quantitative and quantitative RT-PCR analyses
Total RNA was extracted from mucosal B-1 B cells using
RNAeasy (Qiagen, Tokyo, Japan). The cDNA was prepared by
Superscript III First-Strand Synthesis System (InVitrogen) with
oligo(dT) primer. AID, Ia-Cm (aCTs), Im-Ca, and b-actin
transcripts in mucosal B-1 B cells were amplified by oligonucle-
otide primers specific for AID, aCTs, Im-Ca and b-actin
transcripts as described previously [16,33,36,37]. The RT-PCR
products were analyzed on 2% agarose gels. The PCR product
band densities of the respective CSR-associated molecules were
calculated by the PCR product band density of b-actin expression
as 100 with ChemiDoc XRS Quantity One Analysis software (Bio-
Rad). In order to quantitate BAFF and APRIL expression on
mucosal DCs and their receptor expression on B-1 B cells, the
levels of synthesized cDNA of DCs and B-1 B cells from mucosal
tissues were measured using a Nanodrop 2000 RNA/DNA
calculator (Thremo Fisher Scientific Inc.). The sample cDNA
and the external standards were amplified with a pair of specific
primers for APRIL, BAFF, TACI, BCMA and BAFF-R in the
presence of the Power SYBR Green PCR Master Mix (Applied
Biosystems) by a Real-time PCR system (Applied Biosystems). The
concentration of sample cDNA was determined using linear,
diluted external standards obtained by an identical PCR protocol.
Induction of in vitro IgA CSR by mucosal DCs
To examine the function of mucosal DCs for IgA B-1 B cell
CSR, peritoneal IgA
2 B cells were co-cultured with mucosal DCs
from SMGs, NPs and cervical lymph nodes (CLNs) of mice given
nasal TNP-LPS plus nCT, TNP-LPS alone or nCT only in the
presence of IL-5, TGF-b1 or IL-5 and TGF-b1 cytokines. After
stimulation for 5 days, nonadherent cells were harvested and were
then stained with FITC-conjugated anti-IgA and PE-labeled anti-
CD5 mAbs (BD PharMingen). The samples were then analyzed
using the FACSCaliburH (BD Biosciences) and CellQuest software
(BD Immunocytometry Systems).
Statistical analysis
The results are expressed as the mean 6 one standard error of
the mean (SEM). All mouse groups were compared with control
mice using an unpaired Mann-Whitney U test with Statview
software (Abacus Concepts Inc.) designed for Macintosh comput-
ers. P values of ,0.05 were considered significant.
Results
Induction of CSR-associated mRNA in oral mucosal
effector tissues
We initially examined CSR from the m-chain to the a-chain in
B-1 B cells from SMGs and NPs as mucosal effector tissues of
C57BL/6 mice. The mRNA levels specific for activation-induced
cytidine deaminase (AID), aCTs and Im-Ca were analyzed by
Figure 1. Frequencies of IgA
+ B-1 B cells and TNP-LPS-specific
IgA AFCs in the oral-nasopharyngeal effector tissues of TCRb
2/2
mice. (A) TCRb
2/2 mice were nasally immunized with PBS alone, nCT
alone or TNP-LPS (10 mg) with or without nCT (1 mg). Five days after
nasal immunization, mononuclear cells were isolated from SMGs and
NPs and were then stained with FITC-conjugated anti-IgA, PE-labeled
anti-CD5, and APC-tagged anti-B220 mAbs. Samples were subjected to
flow cytometry analysis by FACSCaliburH.* p,0.05 when compared
with TCRb
2/2 mice given TNP-LPS alone, nCT alone or PBS. (B) Five days
after TCRb
2/2 and their genetic background (C57BL/6) mice were
nasally immunized with TNP-LPS (10 mg) plus nCT (1 mg), mononuclear
cells isolated from SMGs and NPs of both groups of mice were
subjected to a TNP-specific IgA AFC ELISPOT assay to determine
numbers of IgA AFCs. *p,0.05 when compared with C57BL/6 mice. The
values are presented as the mean 6 SEM of 10 mice for each group and
a total of five separate experiments.
doi:10.1371/journal.pone.0025396.g001
Mucosal DCs for IgA CSR on B-1 B cells
PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e25396semi-quantitative RT-PCR. As positive controls, B-1 B cells from
NALT of mice given nasal nCT and TNP-LPS were employed. Of
importance, the levels of CSR-associated molecule-specific mRNA
were increased in B-1 B cells from SMGs and NPs of mice given
nasal TNP-LPS plus nCT when compared with those of mice
given nasal TNP-LPS alone or nCT alone (upper section in
Table 1). Although lower levels of AID- and aCTs-specific mRNA
expression were seen in SMGs and NPs when compared with
NALT, Im-Ca-specific mRNA transcripts in these mucosal effector
tissues were essentially the same as those in NALT (Table 1).
These findings indicate that higher levels of IgA CSR are induced
in the oral-nasopharyngeal effector tissues in addition to NALT
when C57BL/6 mice were nasally immunized with TNP-LPS plus
nCT.
T cell-independent IgA CSR occurs in the SMGs and NPs
Since nCT is known to be a potent Ag as well as adjuvant, it is
possible that nasal CT enhances IgA CSR in oral-nasopharyngeal
effector tissues through T cell help. In order to ensure that IgA
CSR was induced in a T cell-independent (TI) manner, we
analyzed the frequencies of IgA-expressing B-1 B cells and the
expression of CSR-associated molecules in TCRb-chain deficient
(TCRb
2/2) mice. Significantly increased numbers of sIgA
+ B-1 B
cells were seen in the SMGs and NPs of TCRb
2/2 mice given
nasal TNP-LPS plus nCT (Figure 1A). In addition, higher levels of
AID, Ia-Cm and Im-Ca-specific mRNA were detected in B-1 B
cells from SMGs, NPs of TCRb
2/2 mice given nasal TNP-LPS
plus nCT than were noted in TCRb
2/2 mice given nasal TNP-
LPS only or nCT alone (lower section in Table 1). However,
increased numbers of TNP-LPS-specific IgA AFCs were not seen
in either SMGs or NPs of TCRb
2/2 mice given nasal TNP-LPS
plus nCT when compared with those of similarly treated normal
C57BL/6 mice (Figure 1B). Taken together, these results indicate
that IgA CSR takes place in the oral-nasopharyngeal effector
tissues in a TI manner. However, the differentiation to IgA-
producing plasma cells may require CD4
+ T cell help.
Increased numbers of activated DCs in mucosal tissues
We next characterized CD11c
+ DCs in SMGs, NPs and NALT,
since DCs are known to play key roles in TI IgA CSR [24,25].
Although numbers of CD11c
+ DCs were unchanged in various
mucosal lymphoid tissues of wild-type mice given nCT as nasal
adjuvant (experimental group) when compared with wild-type
mice given TNP-LPS alone (control group) (Table 2), significant
up-regulation of co-stimulatory molecules was noted (Table 2).
Thus, SMGs, NPs and NALT in the experimental group showed
significantly elevated levels of CD80 and CD86 expression by
CD11c
+ DCs. Interestingly, only NALT DCs from the experi-
mental group showed increased levels of CD40 expression, in
addition to CD80 and CD86 (Table 2). These results indicate that
nasal administration of nCT plus Ag induces activation of DCs in
SMGs, NPs and NALT.
Nasal TNP-LPS plus nCT increases APRIL expression by
DCs in SMGs, NPs and NALT of wild-type mice
Since it has been reported that intestinal DCs induce TI IgA
CSR through APRIL and BAFF molecules [21], we next
examined whether nCT-activated DCs from SMGs and NPs also
express these molecules. The frequencies of APRIL- and BAFF-
expressing DCs were essentially the same among mice given PBS,
TNP-LPS only or nCT only. In contrast, significantly higher
frequencies of APRIL-expressing DCs were noted in SMGs, NPs
and NALT of mice given nasal TNP-LPS plus nCT than in mice
given nasal TNP-LPS or nCT alone (Figure 2A). Although the
frequencies of BAFF-expressing DCs were increased when mice
were also given nCT plus TNP-LPS, this increase was modest
(Figure 2A). Thus, mRNA analyses showed similar patterns of
APRIL- and BAFF-specific mRNA expression by DCs from
SMGs, NPs and NALT (Figure 2B). These results suggest that
APRIL-expressing NALT DCs most likely migrate into the
mucosal effector tissues for the induction of IgA CSR specific for
TI Ag.
Nasal TNP-LPS plus nCT induces BAFF-R, TACI and BCMA
expression by salivary gland-associated B-1 B cells
We next examined the expression of receptors for APRIL and
BAFF molecules by B-1 B cells from SMGs, NPs and NALT of
wild-type mice given TNP-LPS nasally with or without nCT, nCT
alone or PBS. The frequencies of TACI-expressing B-1 B cells
were markedly increased in SMGs and NPs when mice were
nasally immunized with TNP-LPS plus nCT (Figure 3A). In
addition, SMGs showed increased numbers of BAFF-R- and
BCMA-expressing B-1 B cells. These findings suggest that
molecular interactions between DCs and B-1 B cells through
APRIL and their receptors, such as TACI, play a key role in TI
Table 2. The frequencies of CD11c
+ DCs and co-stimulatory molecule expression in wild-type mice given nasal TNP-LPS with or
without nCT
a.
Tissue Nasal Adjuvant % of total lymphocytes % of CD11c
+ DCs
CD11c
a CD40
b CD80
b CD86
b MHC II
b
SMGs nCT 1.860.6 0.560.1 * 2.960.5 *20.964.9 50.268.8
None 2.060.4 0.260.0 0.760.2 11.362.2 46.3610.9
NPs nCT 5.262.1 3.160.8 * 15.262.1 *7.961.3 18.064.2
None 5.662.6 3.461.1 5.260.7 3.761.1 16.963.7
NALT nCT 2.260.5 * 7.761.5 * 18.263.2 *17.262.8 50.6612.2
None 2.160.7 3.761.1 5.561.9 7.462.1 48.169.9
aMononuclear cells from SMGs, NPs and NALT were isolated five days after immunization with TNP-LPS plus nCT or TNP-LPS alone, and were stained with FITC-
conjugated anti-CD11c mAb.
bMononuclear cells were stained with FITC-conjugated anti-CD11c and PE-labeled anti-CD40, -CD80, -CD-86 or -MHC class II mAbs and were then subjected to flow
cytometry analysis by FACSCaliburH.
*p,0.05 compared with immunized mice given TNP-LPS alone.
doi:10.1371/journal.pone.0025396.t002
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hand, mucosal inductive tissues such as NALT contain a relatively
small frequency of CD5
+ B220
+ B cells and the majority of these
cells express BAFF-R when mice were nasally immunized with
TNP-LPS, nCT or TNP-LPS plus nCT (Figure 3A). When nCT
was employed as nasal adjuvant with TI-Ag, BAFF-R but not
TACI or BCMA expression by B-1 B cells was significantly
increased (Figure 3A). These findings indicate that NALT B-1 B
cells are not the source of B-1 B cells in the oral-nasopharyngeal
effector tissues for TI IgA CSR. In support of our FACS results,
increased levels of TACI- and BCMA-specific mRNA were
detected in SMGs of mice given nasal nCT plus TNP-LPS when
compared with mice given nasal TNP-LPS only (Figure 3B).
Further, significantly elevated levels of BCMA-specific mRNA
were seen in B-1 B cells from NPs of mice given TNP-LPS plus
nCT as nasal adjuvant (Fig. 3B). In contrast, essentially no up-
regulation of TACI-, BCMA- or BAFF-R gene expression was
detected in B-1 B cells from NALT (Figure 3B).
Figure 2. APRIL and BAFF expression by CD11c
+ DCs. Mice were nasally immunized with TNP-LPS with or without nCT, nCT alone or PBS. (A)
Five days after immunization, mononuclear cells were isolated from SMGs, NPs and NALT and stained for CD11c, APRIL and BAFF using the respective
fluorescence-conjugated mAbs described in the Materials and Methods section. Samples were subjected to flow cytometric analysis by FACSCaliburH.
*p,0.05 when compared with mice given TNP-LPS or nCT alone. The values are presented as the mean 6 SEM of 10 mice for each group and
represent a total of five separate experiments. (B) CD11c
+ DCs were isolated from SMGs, NPs and NALT of mice given nasal TNP-LPS with or without
nCT by AutoMACS two days after the immunization. The expression of BAFF- and APRIL-specific mRNA by mucosal DCs was determined by
quantitative real-time PCR. Relative expression of BAFF- and APRIL- specific mRNA were displayed as the fold change of respective transcript
expression by experimental group (TNP-LPS plus nCT) over the expression by controls (TNP-LPS alone). The values are presented as the mean 6 SEM
of 10 mice for each group and represent a total of five separate experiments.
doi:10.1371/journal.pone.0025396.g002
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+ B220
+) B cells. Wild-type mice were nasally immunized with TNP-LPS
with or without nCT, nCT alone or PBS. (A) Five days after immunization, mononuclear cells were isolated and stained for CD5, B220, TACI, BCMA and
BAFF using the respective fluorescence-conjugated mAbs as described in the Materials and Methods section. Samples were then subjected to flow
cytometric analysis by FACSCaliburH.* p,0.05 when compared with mice given TNP-LPS or nCT alone. The values are presented as the mean 6 SEM
of 10 mice for each group and represent a total of five separate experiments. (B) B-1 B cells were purified by FACSAria from SMGs, NPs and NALT of
mice given nasal TNP-LPS with or without nCT two days after the immunization. The expression of TACI, BCMA and BAFF-R mRNA by B1-B cells was
assessed by quantitative real-time PCR. Relative expression of TACI, BCMA and BAFF-R mRNA are displayed as the fold change of respective transcript
expression by the experimental group (TNP-LPS plus nCT) over the expression by controls (TNP-LPS alone). The values are presented as the mean 6
SEM of 10 mice for each group and represent a total of five separate experiments.
doi:10.1371/journal.pone.0025396.g003
Mucosal DCs for IgA CSR on B-1 B cells
PLoS ONE | www.plosone.org 6 September 2011 | Volume 6 | Issue 9 | e25396Mucosal DCs induce IgA CSR by B-1 B cells in vivo
To further examine whether NALT-derived DCs directly
induce TI IgA CSR in B-1 B cells, CD11c
+ DCs isolated from
SMGs, NPs and CLNs of mice nasally immunized with TNP-LPS
with/without nCT or nCT alone were cultured with peritoneal
IgA
2, IgM
+ B cells in the presence of TGF-b1, IL-5 or both TGF-
b1 and IL-5. Five days after incubation, non-adherent cells were
isolated and subjected to flow cytometry analysis in order to
determine the frequency of IgA and CD5 expressing B cells. When
adding TGF-b1 alone or IL-5 alone, increased frequencies of IgA
+
B-1 B cells were not seen in every mice group (Table 3). However,
in the presence of both TGF-b1 and IL-5, higher frequencies of
IgA
+ B-1 B cells were seen in cultures containing CD11c
+ DCs
from SMGs, NPs and CLNs of mice nasally treated with TNP-
LPS plus nCT when compared with those cultures incubated with
DCs from mice given TNP-LPS alone or nCT only (Figure 4 and
Table 3). These findings clearly showed that DCs in mucosal
effector tissues play key roles in the induction of B-1 B cell IgA
CSR in the presence of IL-5 and TGF-b1. Induction of IgA CSR
by CLN DCs also indicates that DCs in oral-nasopharyngeal
effector tissues potentially originate from NALT and CLNs since
CLNs drain not only NALT cells but also nasal Ag and adjuvant.
Discussion
We initially investigated the expression of AID, aCT and Im-Ca
molecules involved in the induction of IgA CSR by B-1 B cells
from SMGs and NPs of mice given nCT plus TNP-LPS, since it
has been shown that AID is essential for CSR which specifically
occurs in activated B cells [18,21,23]. Furthermore, aCT and Im-
Ca transcripts are known as a hallmark to demonstrate active
CSR in vivo [37]. As positive controls, the elevated mRNA
expression of these IgA CSR-associated molecules were promi-
nently seen in B-1 B cells from NALT of mice given TNP-LPS
plus nCT. Interestingly, we also noted higher expression of IgA
CSR-associated molecules by B-1 B cells in SMGs and NPs when
compared with those from mice given nasal TNP-LPS or nCT
alone. These results clearly show that TI IgA CSR takes place in
the oral-nasopharyngeal effector tissues. Indeed, it has been well
accepted that a TI IgA CSR pathway exists in the intestinal
mucosa in addition to the classical T cell-dependent one [38].
Thus, intestinal IgA Abs are produced by B-1 B cells in diffuse
effector lymphoid tissues such as intestinal lamina propria and are
derived from the peritoneal cavity [31]. Despite these reports, our
results are the first to show that up-regulation of the TI m to a
isotype CSR by B-1 B cells occurs in the oral-nasopharyngeal
effector tissues in addition to the intestinal effector tissues when
nCT was employed with TI-Ag as nasal adjuvant.
Since nasal nCT possesses strong adjuvant activity to enhance
CD4
+ T cell function [11], it was possible that the enhancement of
IgA CSR may be induced by activated CD4
+ T cells and their
derived cytokines. Our previous results clearly showed that
increased numbers of IgA
+ B-1 B cells in both SMGs and NPs
was only noted in mice given nasal TNP-LPS plus nCT, but not
from mice given nasal TNP-LPS alone [34]. To eliminate the
potential role for nCT-activated CD4
+ T cells, TCRb deficient
(TCRb
2/2) mice were nasally immunized with TNP-LPS plus
nCT. Our results revealed that AID, aCT and Im-Ca transcripts
were upregulated in SMGs and NPs of TCRb
2/2 mice given
nasal TNP-LPS plus nCT as mucosal adjuvant. To this end, the
frequencies of IgA
+ B-1 B cells and expression levels of IgA CSR-
associated molecules in TCRb
2/2 mice were essentially the same
as those detected in C57BL/6 mice (Table 1 and Fig. 1).
Interestingly, TCRb
2/2 mice given nasal nCT showed reduced
numbers of TNP-LPS-specific IgA AFCs in both SMGs and NPs
when compared with those of normal controls given nasal TNP-
LPS plus nCT. These results agree with our previous finding that
CD4
+ T cell-derived IL-5 is essential for TNP-LPS-specific IgA Ab
synthesis [34]. Taken together, induction of IgA CSR by B-1 B
cells, but reduced TNP-LPS-specific IgA AFCs in TCRb
2/2
mice, clearly indicate that nasal nCT plus TI-Ag enhances IgA
CSR in SMGs and NPs in a T cell-independent manner; however,
the subsequent events for the final differentiation of IgA
+ B cells to
IgA-producing plasma cells requires IL-5-producing CD4
+ T cells.
It has been reported that both intestinal DCs and epithelial cells
induce CD40-independent IgA CSR through BAFF and APRIL
molecules [18,21]. However, it still remains unclear whether DCs
in oral-nasopharyngeal mucosal effector tissues express these
molecules and serve a similar function as intestinal DCs. In order
to shed light on the cellular and molecular mechanisms of TI IgA
CSR in SMGs and NPs, we focused on DCs in SMGs and NPs for
their potential roles in the induction of TI m to a isotype CSR. Our
Table 3. Induction of IgA CSR on B-1 B cells co-cultured with DCs plus cytokines
a.
Nasal Immunization with DCs from (4610
5 cells/ml) %o fI g A + cells on B-1 B cells
IL-5 (100 ng/ml) TGF-b1 (1 ng/ml) IL-5 (100 ng/ml)+TGF-b1 (1 ng/ml)
nCT SMGs 0.560.2 0.260.2 0.860.3
NPs 0.460.2 0.260.3 0.760.2
CLNs 0.260.3 0.060.2 0.560.2
TNP-LPS SMGs 0.460.4 0.260.8 1.960.8
NPs 0.360.2 0.360.2 1.260.4
CLNs 0.460.5 0.262.6 0.960.3
TNP-LPS + nCT SMGs 0.560.1 0.360.1 *
, #4.860.5
NPs 0.460.2 0.460.2 *
, #2.760.7
CLNs 0.460.3 0.460.1 *
, #2.460.7
aIgA negative B cells from SMGs, NPs and CLNs from the peritoneal cavity cells were co-cultured with DCs plus IL-5, TGF-b1, or both IL-5 and TGF-b1 for five days, and
were stained with FITC-conjugated anti-IgA mAb and were then subjected to flow cytometry analysis by FACSCaliburH.
*p,0.05 compared with immunized mice given TNP-LPS alone.
#p,0.05 compared with immunized mice given nCT alone.
doi:10.1371/journal.pone.0025396.t003
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CD11c
+ DCs in SMGs and NPs of mice given TNP-LPS plus nCT
when compared with those expressed by CD11c
+ DCs from mice
given nasal TNP-LPS or nCT alone. Further, when DCs from
SMGs and NPs of mice given nasal TNP-LPS plus nCT were co-
cultured with IgA
2 B cells from the peritoneal cavity in the
presence of both IL-5 and TGF-b1, high numbers of IgA
+ B-1 B
cells were induced. On the other hand, cultures containing DCs
from SMGs or NPs of mice given nasal TNP-LPS or nCT alone
revealed essentially the same frequencies of IgA
+ B-1 B cells as
seen in cultures containing B cells only (data not shown). These
results clearly showed that APRIL-expressing DCs play a key role
in IgA CSR by B-1 B cells in oral-nasopharyngeal effector tissues
such as SMGs and NPs. It was recently reported that intestinal
DCs activated through TLR5 signaling produce retinoic acid (RA)
and induce IgA Ab production by peritoneal B-1 B cells [39].
Thus, it is possible that nasal nCT-stimulated DCs in SMGs and
NPs produce RA for the induction of TNP-LPS-specific S-IgA Ab
responses. Indeed, our results revealed increased levels of CD40,
CD80, CD86 and MHC class II expression by DCs isolated from
SMGs and NPs of mice given TNP-LPS plus nCT. However,
nasal nCT failed to upregulate levels of retinal dehydrogenase
(which converts retinal into retinoic acid)-specific mRNA expres-
sion by oral-nasopharyngeal DCs (data not shown). These results
Figure 4. Induction of IgA CSR by B-1 B cells in the presence of mucosal DCs. IgA negative B cells were purified from the peritoneal cavity of
wild-type mice by magnetic sorting. Purified cells (8610
6 cells/ml) were then cultured with DCs (4610
5 cells/ml) from SMGs, NPs and CLNs of mice
given nasal TNP-LPS with/without nCT or nCT alone in the presence of 1 ng/ml TGF-b1, and 100 ng/ml IL-5. After 5 days of incubation, non-adherent
cells were harvested and stained with FITC-conjugated anti-IgA, and PE-labeled anti-CD5 mAbs. The data represent a typical profile of 10 mice for
each group.
doi:10.1371/journal.pone.0025396.g004
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synthesis by mucosal CD4
+ T cells is essential for the induction of
TNP-LPS-specific S-IgA Abs [34]. Taken together, our present
study indicates that nasal nCT stimulated DCs in SMGs and NPs
play a central role in IgA CSR, but not in the induction of
terminal B cell differentiation into IgA-producing plasma cells.
B-1 B cells, known to be a minor subset comprising ,5% of the
total B cell population in the mouse and human periphery, arise
during fetal development and have a restricted B cell receptor
repertoire [40]. It has been previously reported that two distinct
lineages of sIgA
+ B cells developed from B-1 and B-2 B cells and
both, are involved in the induction of S-IgA Abs for mucosal
immunity [41,42]. In addition, peritoneal B-1 B cells and splenic
marginal zone B cells play a central role in the induction of TI IgA
Ab responses [31,32]. Importantly, it has been reported that B-1 B
cells express receptors for BAFF and APRIL-BAFF-R and TACI,
respectively [43]. Since BAFF and APRIL are able to interact with
their potential receptors such as BAFF receptor, BCMA and
TACI molecules, it was important to identify which receptors on
B-1 B cells in oral-nasopharyngeal effector tissues are responsible
for the induction of IgA CSR. Higher frequencies of TACI-
expressing B-1 B cells were detected in SMGs and NPs of mice
given nasal nCT plus TNP-LPS than those cells from mice given
nasal TNP-LPS only. These results agree with previous reports
that APRIL promotes T cell-independent IgA CSR through
engagement of TACI in vitro [21,22]. Further, it has been shown
that APRIL on DCs interacts with BCMA and TACI on B cells for
the induction of IgA CSR [44]. In this regard, SMG B-1 B cells
also showed increased numbers of BCMA-expressing B-1 B cells
when mice were nasally immunized with TNP-LPS plus nCT.
Taken together, these findings suggest that molecular interactions
between APRIL-expressing DCs and TACI- or BCMA-bearing B-
1 B cells play a major role in T cell independent IgA CSR in
SMGs and NPs.
In summary, although it was evident that TI IgA isotype class
switching occurs in diffuse mucosal effector tissues such as the
intestinal lamina propria, our present study clearly showed that
this event also takes place in oral-nasopharyngeal effector tissues.
Further, nasal nCT as mucosal adjuvant enhanced IgA CSR in the
SMGs and NPs for subsequent S-IgA Ab production. Thus,
CD11c
+ DCs from SMGs and NPs induce T cell independent IgA
CSR by sIgM
+ IgA
2 B-1 B cells through interactions between
APRIL and TACI/BCMA molecules. However, T cell deficiency
abolished enhancement of TNP-LPS-specific S-IgA Ab responses
by nCT. Taken together, the nasal adjuvant effect of nCT in TI-
Ag-specific IgA Ab responses were uniquely regulated by TI IgA
CSR by DC-B-1 B cell interactions. In the present study, we have
elucidated a novel cellular and molecular mechanism for nCT
adjuvanticity for the induction of TI-Ag-specific immunity in the
oral-nasopharyngeal tract. It has yet to be shown that nCT serves
a similar function in the GI tract. This will be elucidated in our
future studies.
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